{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:03Z","timestamp":1792785843771,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1K23HL151826"],"award-info":[{"award-number":["1K23HL151826"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["3R01AI152078-01S1"],"award-info":[{"award-number":["3R01AI152078-01S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U24TR001609-S3"],"award-info":[{"award-number":["U24TR001609-S3"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR00309"],"award-info":[{"award-number":["UL1TR00309"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mental Wellness Foundation"},{"name":"HealthNetwork Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is a safe and effective treatment for COVID-19 in immunocompromised (IC) patients. IC patients have a higher risk of persistent infection, severe disease, and death from COVID-19. Despite the continued clinical use of CCP to treat IC patients, the optimal dose, frequency\/schedule, and duration of CCP treatment has yet to be determined, and related best practices guidelines are lacking. A group of individuals with expertise spanning infectious diseases, virology and transfusion medicine was assembled to render an expert opinion statement pertaining to the use of CCP for IC patients. For optimal effect, CCP should be recently and locally collected to match circulating variant. CCP should be considered for the treatment of IC patients with acute and protracted COVID-19; dosage depends on clinical setting (acute vs protracted COVID-19). CCP containing high-titer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, retains activity against circulating SARS-CoV-2 variants, which have otherwise rendered monoclonal antibodies ineffective.<\/jats:p>","DOI":"10.1093\/cid\/ciad066","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:54:07Z","timestamp":1675472047000},"page":"2018-2024","source":"Crossref","is-referenced-by-count":53,"title":["Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":false,"given":"Evan M","family":"Bloch","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Focosi","sequence":"additional","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-7786","authenticated-orcid":false,"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon","family":"Senefeld","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A R","family":"Tobian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R","family":"Baden","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Brigham and Women's Hospital , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tiberghien","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang, La Plaine-St-Denis and Universit\u00e9 de Franche-Comt\u00e9 , Besan\u00e7on , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cohn","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis , Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dioverti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P","family":"Henderson","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine (Division of Infectious Diseases) and Molecular Microbiology, Washington University School of Medicine , St. Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"So-Osman","sequence":"additional","affiliation":[{"name":"Department Transfusion Medicine, Division Blood Bank, Sanquin Blood Supply Foundation , Amsterdam , The Netherlands"},{"name":"Department Haematology, Erasmus Medical Centre , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin E","family":"Juskewitch","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester campus , Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund R","family":"Razonable","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Transfusion Medicine, Carlo Poma Hospital , Mantua , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Simmons Cancer Institute at SIU School of Medicine and Mississippi Valley Regional Blood Center , Springfield, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda J","family":"Grossman","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9167","authenticated-orcid":false,"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Joyner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-3619","authenticated-orcid":false,"given":"Robin K","family":"Avery","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liise-anne","family":"Pirofski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Infectious Diseases, Albert Einstein College of Medicine , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A","family":"Gebo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"2023060818541320900_ciad066-B1","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J Clin Invest"},{"key":"2023060818541320900_ciad066-B2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety update: cOVID-19 convalescent plasma in 20,000 hospitalized patients","volume":"95","author":"Joyner","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2023060818541320900_ciad066-B3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe COVID-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060818541320900_ciad066-B4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for COVID-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N Engl J Med"},{"key":"2023060818541320900_ciad066-B5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from COVID-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060818541320900_ciad066-B6","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"key":"2023060818541320900_ciad066-B7","doi-asserted-by":"crossref","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis","volume":"16","author":"Booth","year":"2021","journal-title":"PLoS One"},{"key":"2023060818541320900_ciad066-B8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40472-022-00385-y","article-title":"Immunocompromised patients with protracted COVID-19: a review of \u201clong persisters.\u201d","volume":"9","author":"Dioverti","year":"2022","journal-title":"Curr Transpl Rep"},{"key":"2023060818541320900_ciad066-B9","doi-asserted-by":"crossref","first-page":"e2250647","DOI":"10.1001\/jamanetworkopen.2022.50647","article-title":"COVID-19 Convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis","volume":"6","author":"Senefeld","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2023060818541320900_ciad066-B10","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1038\/s41467-022-33864-y","article-title":"Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources","volume":"13","author":"Sullivan","year":"2022","journal-title":"Nat Commun"},{"key":"2023060818541320900_ciad066-B11","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2020008423","article-title":"Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19","volume":"136","author":"Hueso","year":"2020","journal-title":"Blood"},{"key":"2023060818541320900_ciad066-B12","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1182\/bloodadvances.2022008932","article-title":"Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19","volume":"6","author":"Ripoll","year":"2022","journal-title":"Blood Adv"},{"key":"2023060818541320900_ciad066-B13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.mayocp.2021.11.001","article-title":"Vax-plasma in patients with refractory COVID-19","volume":"97","author":"Ordaya","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"2023060818541320900_ciad066-B14","first-page":"Cd013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"5","author":"Piechotta","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2023060818541320900_ciad066-B15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmi.2022.08.005","article-title":"Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial","volume":"29","author":"Gharbharan","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2023060818541320900_ciad066-B16","doi-asserted-by":"crossref","first-page":"e00765-21","DOI":"10.1128\/mBio.00765-21","article-title":"Markers of polyfunctional SARS-CoV-2 antibodies in convalescent plasma","volume":"12","author":"Natarajan","year":"2021","journal-title":"mBio"},{"key":"2023060818541320900_ciad066-B17","doi-asserted-by":"crossref","first-page":"102554","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in COVID-19: possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2023060818541320900_ciad066-B18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMc2209952","article-title":"Efficacy of antiviral agents against the Omicron subvariant BA.2.75","volume":"387","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"2023060818541320900_ciad066-B19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/TP.0000000000004340","article-title":"PASC in solid organ transplant recipients with self-reported SARS-CoV-2 infection","volume":"107","author":"Alasfar","year":"2022","journal-title":"Transplantation"},{"key":"2023060818541320900_ciad066-B20","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/trf.16525","article-title":"Use of convalescent plasma in COVID-19 patients with immunosuppression","volume":"61","author":"Senefeld","year":"2021","journal-title":"Transfusion"},{"key":"2023060818541320900_ciad066-B21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41375-022-01511-6","article-title":"Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis","volume":"36","author":"Hueso","year":"2022","journal-title":"Leukemia"},{"key":"2023060818541320900_ciad066-B22","author":"FDA"},{"key":"2023060818541320900_ciad066-B23","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7326\/M22-1079","article-title":"Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma","volume":"175","author":"Estcourt","year":"2022","journal-title":"Ann Intern Med"},{"key":"2023060818541320900_ciad066-B24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41375-022-01578-1","article-title":"Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)","volume":"36","author":"Cesaro","year":"2022","journal-title":"Leukemia"},{"key":"2023060818541320900_ciad066-B25","author":"IDSA"},{"key":"2023060818541320900_ciad066-B26","author":"NIH"},{"key":"2023060818541320900_ciad066-B27","first-page":"96","article-title":"Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity: a randomized clinical trial","volume":"4","author":"Denkinger","year":"2023","journal-title":"Nat Cancer"},{"key":"2023060818541320900_ciad066-B28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.18450","article-title":"Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents","volume":"199","author":"Gachoud","year":"2022","journal-title":"Br J Haematol"},{"key":"2023060818541320900_ciad066-B29","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/bjh.18544","article-title":"Lower anti-spike levels in B-cell-depleted patients after convalescent plasma transfusion suggest the need for repeated doses","volume":"200","author":"Focosi","year":"2023","journal-title":"Br J Haematol"},{"key":"2023060818541320900_ciad066-B30","doi-asserted-by":"crossref","first-page":"103326","DOI":"10.1016\/j.transci.2021.103326","article-title":"SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors","volume":"61","author":"Leon","year":"2022","journal-title":"Transfus Apher Sci"},{"key":"2023060818541320900_ciad066-B31","doi-asserted-by":"crossref","first-page":"e1003872","DOI":"10.1371\/journal.pmed.1003872","article-title":"Access to and safety of COVID-19 convalescent plasma in the United States expanded access program: a national registry study","volume":"18","author":"Senefeld","year":"2021","journal-title":"PLoS Med"},{"key":"2023060818541320900_ciad066-B32","first-page":"1098","article-title":"Clinical and virological response to convalescent plasma in a chronic lymphocytic leukemia patient with COVID-19 pneumonia","volume":"12","author":"Belcari","year":"2022","journal-title":"Life (Basel)"},{"key":"2023060818541320900_ciad066-B33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2022.9745","article-title":"Updated US infection- and vaccine-induced SARS-CoV-2 seroprevalence estimates based on blood donations, July 2020\u2013December 2021","volume":"328","author":"Jones","year":"2022","journal-title":"JAMA"},{"key":"2023060818541320900_ciad066-B34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/trf.16401","article-title":"Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors","volume":"61","author":"Vickers","year":"2021","journal-title":"Transfusion"},{"key":"2023060818541320900_ciad066-B35","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/bloodadvances.2022007410","article-title":"Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern","volume":"6","author":"Li","year":"2022","journal-title":"Blood Adv"},{"key":"2023060818541320900_ciad066-B36","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1038\/s41467-022-33864-y","article-title":"Analysis of anti-SARS-CoV2 Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources","volume":"13","author":"Sullivan","year":"2022","journal-title":"Nat Commun"},{"key":"2023060818541320900_ciad066-B37","author":"Sullivan"},{"key":"2023060818541320900_ciad066-B38","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMoa2103784","article-title":"Early convalescent plasma for high-risk outpatients with COVID-19","volume":"385","author":"Korley","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060818541320900_ciad066-B39","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1038\/s41467-021-25113-5","article-title":"Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors","volume":"12","author":"Kunze","year":"2021","journal-title":"Nat Commun"},{"key":"2023060818541320900_ciad066-B40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/tme.12739","article-title":"ABO-incompatible convalescent plasma transfusion: yes, you can","volume":"31","author":"Focosi","year":"2021","journal-title":"Transfusion Med"},{"key":"2023060818541320900_ciad066-B41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/trf.16871","article-title":"How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?","volume":"62","author":"Bloch","year":"2022","journal-title":"Transfusion"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad066\/49329504\/ciad066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/11\/2018\/50541618\/ciad066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/11\/2018\/50541618\/ciad066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T14:55:04Z","timestamp":1686236104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/11\/2018\/7026329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2023,6,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad066","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,2,6]]}}}